HOME >> BIOLOGY >> NEWS
UCSD, VA and Cal-(IT) wireless technology to enhance mass casualty treatment in disasters

SAN DIEGO, CA -- The use of sophisticated wireless technology to coordinate and enhance care of mass casualties in a terrorist attack or natural disaster is the focus of a new federally funded research project at the University of California, San Diego (UCSD). The project brings together broad-based participation from academia, industry, the military, and emergency responders from the City and County of San Diego.

Called the Wireless Internet Information System for Medical Response in Disasters, or WIISARD, the project is funded by a three-year, $4.1 million grant from the National Library of Medicine, one of the agencies of the National Institutes of Health, to the UCSD School of Medicine ($3.6 million) and the VA San Diego Healthcare System ($0.5 million).

The goal of WIISARD is to provide emergency personnel and disaster command centers with medical data to track and monitor the condition of hundreds to thousands of victims on a moment-to-moment basis, over a period of hours to days at the disaster site. In addition, WIISARD will develop technologies to enhance communication among emergency team members and ensure their safety by tracking the "hot zone," or location and wind drift of the chemical or radioactive matter used as a weapon of mass destruction against civilians. (See WIISARD Sidebar)

The WIISARD project director is Leslie Lenert, M.D., UCSD associate professor of medicine and chief of the Laboratory for the Study of Patients' Preferences at the VA San Diego Healthcare System. In addition to his medical background, Lenert holds an M.S. in Medical Information Sciences (now called Biomedical Informatics) from Stanford University.

"We believe that the current technologies supporting acute field care of victims of disasters are simply inadequate," Lenert said. "The new technologies deployed by WIISARD will bring cutting edge wireless Internet technologies from the hospital to the mass-casualty field treatment station. E
'"/>

Contact: Sue Pondrom
spondrom@ucsd.edu
619-543-6163
University of California - San Diego
23-Oct-2003


Page: 1 2 3 4 5

Related biology news :

1. Prominent UCSD, Salk reseachers to discuss politics and science of embryonic stem cell research
2. High-tech institute to hold Cal-(IT)Day@UCSD
3. Cal-(IT)2 adds new industrial partner SGI
4. Livestock health sensors and wireless data storage in the works
5. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
6. AACR applauds NCI initiative on nanotechnology
7. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
8. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
9. Researchers show how to assemble building blocks for nanotechnology
10. Jefferson Lab detector technology aids development of cystic fibrosis therapy
11. National Academies Advisory: Sept. 18-19 Nanotechnology Conference

Post Your Comments:
(Date:5/24/2013)... 24, 2013 A frequently expressed concern in the ongoing ... fresh vegetables, especially those that are nutrient dense. ... and Beans Provide Most Nutrients Per Penny," published in ... are one of the best nutritional values in the ... per penny than most other raw vegetables and delivering ...
(Date:5/24/2013)... detection and destruction by the immune system. Stimulation of ... however, there are many factors that cause the immune ... immune cells that function to suppress the immune system ... Clinical Investigation , researchers led by Ronald Levy at ... tumors express proteins that can be targeted with therapeutic ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
Breaking Biology News(10 mins):New research shows that potatoes provide one of the best nutritional values per penny 2A new strategy required in the search for Alzheimer's drugs? 2
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan ... human cord blood stem cell banking and therapeutics, announced ... the No. 16 Acorn Stairlifts Indy car driven by ... the remainder of the IZOD IndyCar 2013 season.   ... will work to support awareness of umbilical cord blood ...
(Date:5/23/2013)... Calif. , May 23, 2013 ... a strategic alliance with DAK Renewable Research to ... corn oil yield. VG Energy is a majority ... Pink: VGLS). VG Energy,s exclusively licensed ... increase the oil yield in plants, possessing a ...
(Date:5/23/2013)... , May 23, 2013 BioTrends Research ... advisory firms for specialized biopharmaceutical issues, finds that, ... infectious disease specialists reported that in the past ... intentionally delaying treatment) in anticipation of the next ... months ago, when only 6 percent reported that ...
(Date:5/23/2013)... 23, 2013 Northwest Biotherapeutics (NASDAQ: ... ® personalized immune therapies for solid tumor cancers, ... this year,s American Society Of Clinical Oncology (ASCO) meeting ... leadership role in immune therapy.  (Logo: ... is the pre-eminent conference focused on clinical treatment of ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: